---
title: "secondary prevention of clinical ascvd in patients with preexisting occlusive vascular disease"
slug: "secondary-prevention-of-clinical-ascvd-in-patients-with-preexisting-occlusive-vascular-disease"
date: "2023-02-23"
enableToc: false
tags:
- building
---

> [!info]
>
> ðŸŒ± ä¾†è‡ª: [[2018 ACC AHA Cholesterol Guidelines]]

# secondary prevention of clinical ascvd in patients with preexisting occlusive vascular disease

## Age â‰¤75 without safety concerns	
High- or maximally tolerated intensity statin to achieve LDL-C lowering of 50% or greater

## Age â‰¥75 years	
Start moderate- or high-intensity statin therapy after evaluation of the potential ASCVD reduction, frailty, and drug interactions

## Any patient with concern for statin intolerance
Moderate-intensity statin therapy with aim to achieve 30% to 49% reduction in LDL-C
